Equities

UDG Healthcare plc

UDG Healthcare plc

Actions
Health CareHealth Care Equipment & Services
  • Price (GBX)1,025.00
  • Today's Change6.00 / 0.59%
  • Shares traded5.36m
  • 1 Year change+72.85%
  • Beta0.7134
Data delayed at least 20 minutes, as of May 14 2021 16:45 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Friday, UDG Healthcare plc (UDG:LSE) closed at 1,025.00, -1.16% below its 52-week high of 1,037.00, set on May 12, 2021.
52-week range
Today
584.00May 15 20201,037.00May 12 2021
Markit short selling activity
Low
Med
High
Open1,019.00
High1,025.00
Low1,017.00
Bid1,017.00
Offer--
Previous close1,019.00
Average volume3.36m
Shares outstanding251.88m
Free float251.04m
P/E (TTM)43.02
Market cap2.58bn GBP
EPS (TTM)0.2383
GBP
Annual div (ADY)--
Annual div yield (ADY)1.25%
Div ex-dateJan 07 2021
Div pay-dateFeb 05 2021
Data delayed at least 20 minutes, as of May 14 2021 16:45 BST.
More ▼

Investors Chronicle View

The last IC recommendation on UDG Healthcare plc shares was Hold at 1,020.00 on 12 May 2021Read the full article

Board of Directors

1/11

Shane Cooke, Chairman

2/11
3/11
4/11
5/11
6/11
7/11
8/11
9/11

Liz Shanahan, Non-Executive Director

10/11

Anne Whitaker, Non-Executive Director

11/11

Damien Moynagh, General Counsel & Company Secretary

Contact

Address:
UDG Healthcare
20 Riverwalk
Citywest Business Campus
Citywest
Dublin 24
Ireland

T: +353 1 468 9000
E: company.secretary@udghealthcare.com
investor@udghealthcare.com

Investor Relations:
Nigel Clerkin, CFO
Keith Byrne, Head of Investor Relations & Strategy

T: + 353 1 468 9000
E: investor@udghealthcare.com
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.